Human CD30/TNFRSF8 HEK293T Stable Cell Line

Introduction

The Human CD30/TNFRSF8 HEK293T Stable Cell Line is a valuable tool for the study of CD30, a cell surface receptor that belongs to the tumor necrosis factor receptor superfamily. This stable cell line is derived from HEK293T cells, a human embryonic kidney cell line that is commonly used in research due to its high transfection efficiency and ability to express high levels of exogenous proteins. In this article, we will provide a detailed description of the structure, activity, and applications of the Human CD30/TNFRSF8 HEK293T Stable Cell Line.

Structure

The Human CD30/TNFRSF8 HEK293T Stable Cell Line is engineered to stably express the human CD30 protein on the cell surface. CD30 is a type I transmembrane protein that consists of 595 amino acids and has a molecular weight of approximately 120 kDa. It is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain of CD30 contains four cysteine-rich domains, which are important for ligand binding and receptor activation. The cytoplasmic tail of CD30 contains multiple signaling motifs, including a TRAF-binding domain, which is crucial for downstream signaling.

Activity

The main function of CD30 is to act as a receptor for its ligand, CD30L. Upon binding to CD30L, CD30 undergoes conformational changes that lead to the recruitment of TRAF proteins and the activation of downstream signaling pathways. CD30 signaling has been implicated in various cellular processes, including cell proliferation, differentiation, and survival. Aberrant CD30 signaling has also been linked to the development of various diseases, including cancer and autoimmune disorders.

Application

The Human CD30/TNFRSF8 HEK293T Stable Cell Line has been widely used in research to study the structure and function of CD30. One of the main applications of this cell line is in the field of immunology, where it is used to investigate the role of CD30 in immune cell activation and regulation. For example, the stable expression of CD30 on the surface of HEK293T cells allows for the study of CD30-mediated signaling pathways and the identification of novel CD30-binding partners.

Another important application of the Human CD30/TNFRSF8 HEK293T Stable Cell Line is in drug discovery and development. CD30 has been identified as a potential therapeutic target for various diseases, including Hodgkin’s lymphoma and other CD30-positive cancers. The stable expression of CD30 in this cell line provides a valuable tool for screening and evaluating potential CD30-targeting drugs. In addition, the Human CD30/TNFRSF8 HEK293T Stable Cell Line can also be used in flow cytometry assays to assess the binding of CD30-targeting antibodies and other potential therapeutics.

Conclusion

In summary, the Human CD30/TNFRSF8 HEK293T Stable Cell Line is a valuable tool for the study of CD30 and its role in various cellular processes and diseases. Its stable expression of CD30 allows for the investigation of CD30-mediated signaling pathways and the identification of potential therapeutic targets. This cell line is widely used in immunology research and drug discovery, and its application is not limited to the fields mentioned in this article. With its versatility and reliability, the Human CD30/TNFRSF8 HEK293T Stable Cell Line is an essential tool for any researcher interested in the study of CD30.